9,10-Deepithio-9,10-Didehydroacanthifolicin

DB02169ExperimentalSmall molecule

A specific inhibitor of phosphoserine/threonine protein phosphatase 1 and 2a. It is also a potent tumor promoter. (Thromb Res 1992;67(4):345-54 & Cancer Res 1993;53(2):239-41).

Formula / weight: C₄₄H₆₈O₁₃ · 805.0029 g/mol (avg)
Code names: NSC-677083

Resolves to

Compound

UNII1W21G5Q4N2CAS78111-17-8ChEMBLCHEMBL280487ChEBI44658PubChem446512KEGGC01945

Structure

InChIKeyQNDVLZJODHBUFM-WFXQOWMNSA-NSMILES

[H]\C(=C(\[H])[C@@]1([H])CC[C@@]2(CC[C@@]3([H])O[C@@]([H])(C(=C)[C@@]([H])(O)[C@]3([H])O2)[C@@]([H])(O)C[C@]([H])(C)[C@@]2([H])O[C@@]3(CCCCO3)CC[C@@]2([H])C)O1)[C@@]([H])(C)[C@]1([H])CC(C)=C[C@@]2(O[C@]([H])(C[C@@](C)(O)C(O)=O)CC[C@@]2([H])O)O1

Targets

P28562DUSP1P36873PPP1CC

What you can answer from here — as of September 13, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with 9,10-Deepithio-9,10-Didehydroacanthifolicin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account